1. From the Stroke Programme (S.A.), Catalan Agency for Health Information, Assessment and Quality (CAHIAQ), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP; S.A., A.R.), Spain; The Cat-SCT Steering Committee (A.D., A.C., J.A.-S.), Barcelona, Spain; the Cardiovascular Epidemiology Unit (A.R.), Hospital Vall d'Hebron, Barcelona, Spain; and the Stroke Programme (M.G.), Health Department, Generalitat de Catalunya, Barcelona, Spain.